transmedics.com
Management Team: TransMedics, Inc.
http://www.transmedics.com/wt/page/mgmt
Waleed Hassanein, MD. Tamer Khayal, MD. Jacqueline Sneve, MPA. Board of Directors and Observers. TransMedics executive team has deep knowledge and experience in medical devices and technology. Waleed Hassanein, M.D. TransMedics Founder, President, and CEO. Vice President of Business Development. Vice President of Operations. Tamer Khayal, MD. Vice President of Global Marketing. Jacqueline Sneve, MPA. Vice President, Healthcare Economics and Reimbursement. Vice President of Engineering.
transmedics.com
Key Advantages: TransMedics, Inc.
http://www.transmedics.com/wt/page/advantages
What are the Benefits of the TransMedics Organ Care System? Since the advent of transplantation, the cornerstone of organ preservation has been cold ischemic storage. Although this method was intended to help reduce the extent of organ damage during transport, significant damage still occurs. The more time that passes, the more damage occurs. We have designed the Organ Care System to offer the following potential advantages over cold ischemic preservation:. Increased utilization of available organs.
transmedics.com
Site Map: TransMedics, Inc.
http://www.transmedics.com/wt/page/sitemap
Board of Directors and Observers. 2016 TransMedics, Inc.
transmedics.com
How It Works: TransMedics, Inc.
http://www.transmedics.com/wt/page/how_works
Enabling the functional assessment of organs for the first time outside of the body. How Does the TransMedics Organ Care System Work? The Organ Care System is comprised of two principal components, a portable platform and an organ specific perfusion set, operating together as an integrated technology:. Organs that are maintained in a functioning state outside the body continue to utilize nutrients as they would in vivo. US: Caution Investigational Device. Limited by Federal Law to investigational use.
transmedics.com
OCS Lung: TransMedics, Inc.
http://www.transmedics.com/wt/redirect/lung_preservation_med
The World's Only Portable Lung Perfusion System. Lung transplantation programs around the world face significant challenges in organ availability, patient outcomes, and overall cost of patient care caused by the limitations of the current cold static lung preservation method. The OCS™ LUNG is now commercially available in Europe and Australia and is in clinical use in leading centers. Clinical trials in the U.S. are currently enrolling. Not commercially available in the U.S. 2016 TransMedics, Inc.
transmedics.com
Liver Preservation: TransMedics, Inc.
http://www.transmedics.com/wt/page/ocsliverintro_med
The Next Generation of Normothermic Liver Perfusion and Preservation. Liver transplantation programs around the world face significant challenges in organ availability, patient outcomes, and overall cost of patient care caused by the limitations of the current cold static liver preservation method. The OCS Liver PROTECT clinical trial is currently initiating. Please click here. 2016 TransMedics, Inc.
transmedics.com
Corporate Information: TransMedics, Inc.
http://www.transmedics.com/wt/page/corporate
Andover, MA 01810. Phone: 978.552.0900. Fax: 978.552.0978. Board of Directors and Observers. Headquartered in Andover, Massachusetts, TransMedics™ is a medical device company founded to address the unmet need for better, more effective organ transplant technologies. The company, which began commercial operations in 2000, has developed the first commercial, portable warm blood perfusion system that allows for a new type of organ transplant, called a living organ transplant. The Organ Care System. Despite ...
transmedics.com
Board of Directors & Observers: TransMedics, Inc.
http://www.transmedics.com/wt/page/bod
Board of Directors and Observers. Board of Directors and Observers. James R. Tobin. Edward M. Basile. Thomas J. Gunderson. Waleed Hassanein, M.D. Edwin M. Kania, Jr. Dmitry Kobyzev, Ph.D. TransMedics Board of Directors and Observers. James R. Tobin. Chairman of TransMedics Board. Edward M. Basile. Thomas J. Gunderson. Waleed Hassanein, M.D. President and Chief Executive Officer. Edwin M. Kania, Jr. Dmitry Kobyzev, Ph.D. 2016 TransMedics, Inc.
transmedics.com
OCS Heart: Portable Perfusion and Monitoring: TransMedics, Inc.
http://www.transmedics.com/wt/redirect/heart_preservation_med
OCS Heart: Portable Perfusion and Monitoring. OCS™ HEART: Portable Perfusion and Monitoring. Heart Programs Face Challenges. OCS™ HEART has Potential to. Reduce Cost of Patient Care. A Breakthrough in Heart Preservation. The World's Only Portable Heart Perfusion System. TransMedics developed the OCS™ HEART system to overcome these challenges. This portable, warm perfusion and monitoring system is designed to. Reduce cost of patient care. OCS™ HEART, a Breakthrough. 2016 TransMedics, Inc.
transmedics.com
Medical Professionals: TransMedics, Inc.
http://www.transmedics.com/wt/full/med_professionals
Learn About Heart and Lung Preservation. TransMedics' mission is to enable surgeons to transplant more organs from the available donor pool and to achieve even better procedural outcomes while reducing the overall treatment costs associated with end-stage organ failure. Please choose an area of focus to learn more. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. 2016 TransMedics, Inc.